DD293352A5 - PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN - Google Patents

PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN Download PDF

Info

Publication number
DD293352A5
DD293352A5 DD33950390A DD33950390A DD293352A5 DD 293352 A5 DD293352 A5 DD 293352A5 DD 33950390 A DD33950390 A DD 33950390A DD 33950390 A DD33950390 A DD 33950390A DD 293352 A5 DD293352 A5 DD 293352A5
Authority
DD
German Democratic Republic
Prior art keywords
acyl
disubstituted
dihydro
imidazo
acid
Prior art date
Application number
DD33950390A
Other languages
German (de)
Inventor
Heinz Graubaum
Ruediger Ozegowski
Kristina Bigalke
Original Assignee
Adw,Zi Fuer Organische Chemie,De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adw,Zi Fuer Organische Chemie,De filed Critical Adw,Zi Fuer Organische Chemie,De
Priority to DD33950390A priority Critical patent/DD293352A5/en
Publication of DD293352A5 publication Critical patent/DD293352A5/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Herstellung von neuen 2,2-disubstituierten 1-Acyl- und/oder * die erfindungsgemaesz durch Umsetzung von 2,2-disubstituierten * mit einem Arylierungs-/Acylierungsmittel wie Saeurechlorid oder Cyansaeureester in Gegenwart eines saeurebindenden Mittels oder in einem aprotischen Loesungsmittel bei Temperaturen von 100 bis 200C erhalten werden. Die neuen Verbindungen sind fuer biozide Mittel, insbesondere Herbizide, Akarizide, Insektizide, Fungizide und Anthelmintika, verwendbar.{disubstituiertes * disubstituiertes * Acylierung; Saeurechlorid; Kohlensaeure-ester-chlorid; Thiokohlensaeure-O-ester-chlorid; Cyansaeureester; Isocyansaeureester; aprotisches Loesungsmittel; thermische Isomerisierung}The invention relates to a process for the preparation of novel 2,2-disubstituted 1-acyl and / or the invention by reacting 2,2-disubstituted * with an arylating / acylating agent such as acid chloride or cyanate in the presence of an acid-binding agent or in an aprotic solvent at temperatures of 100 to 200C. The new compounds are useful for biocides, especially herbicides, acaricides, insecticides, fungicides and anthelmintics. {Disubstituted * disubstituted * acylation; acid chloride; Carbonic acid ester chloride; Thiocarbonic acid O-ester chloride; cyanate ester; isocyanic; aprotic solvent; thermal isomerization}

Description

Hierzu 1 Seite FormelnFor this 1 page formulas

Anwendungsgebiet der ErfindungField of application of the invention

Die Erfindung betrifft ein Verfahren zur selektiven Herstellung von neuen 2,2-dlsubstltulerten 1 -Acyl- und/oder 9-Acyl-2,3-dihydro-imidazol1,2-albenzimidazol-3-onen, die als Wirkstoffe für biozide Mittel, insbesondere als Herbizide, Akarizlde, Insektizide, Fungizide und Anthelmintika, von Interesse sein können.The invention relates to a process for the selective preparation of novel 2,2-dlsubstltulerten 1-acyl and / or 9-acyl-2,3-dihydro-imidazol1,2-albenzimidazol-3-ones, which are used as active ingredients for biocidal agents, in particular as herbicides, acaricides, insecticides, fungicides and anthelmintics may be of interest.

Charakteristik des bekannten Standes der TechnikCharacteristic of the known state of the art

Es ist bekannt, daß Acyldorivate von 1,3,5,-Triazino[1,2-a]-benzlmidazolen sehr gute herbizide (D. MARTIN, H. GRAUBAUM, J.prakt.Chem.321,315 (1979), DD-PS 242340, DD-PS 227035, DE-OS 2144505, US-PS 4497650), fungizide (DE-OS 2527677) und insektizide (DD-PS 235019) Eigenschaften besitzen. Außerdem sind auch pharmakologische Eigenschaften derTriazino[1,2-albenzimidazole gegen Nematoden, Zutoden und Hakenwürmer (DE-OS 2452365, GB-PS 1522076) bekannt. Acylderivate der lmidazo|1,2-a]benzimidazole sind bishör noch nicht beschrieben. Lediglich die 9-Aryl-2,3-dihydro-imidazo[1,2-ajbenzimldazole sind mit pharmakologischon Eigenschaften In der Literatur (GB-PS 1476949) zitiert. Des weiteren ist das 2,2-Diphenyl-2,3-dihydro-imidazol1,2-a]benzimidazol-3-on durch Thermolyse von 1-Aryl-2-cyano-3,3-diphenyl-diazetidin-4-on darstellbar (CW.BIRD, M.W.KACZMAR, C.K.WONG: Tetrahedron 30,2549 (19741). Die als Ausgangsprodukte benötigten 2,2-disubstituierten 2,3-Dihydro-imidazo[1,2-a]benzimidazol-3-one wurden aus 2-Amino-benzimidazol, Chloroform und Aceton bzw. Cyclohexanon und anschließender Cyclisierung mit Thionylchlorid (H.GRAUBAUM, R.OZEGOWSKI: J.prakt.Chem.: in Vorbereitung) nach bekannten Verfahren hergestellt.It is known that acyldorivatives of 1,3,5-triazino [1,2-a] -benzimidazoles are very good herbicides (D. MARTIN, H. GRAUBAUM, J.prakt.Chem.321,315 (1979), DD-PS 242340, DD-PS 227035, DE-OS 2144505, US-PS 4497650), fungicidal (DE-OS 2527677) and insecticidal (DD-PS 235019) properties. In addition, pharmacological properties of the triazino [1,2-albenzimidazoles against nematodes, clades and hookworms (DE-OS 2,452,365, GB-PS 1522076) are also known. Acyl derivatives of imidazo | 1,2-a] benzimidazoles have not yet been described. Only the 9-aryl-2,3-dihydro-imidazo [1,2-ajbenzimldazole are cited with pharmacological properties in the literature (GB-PS 1476949). Furthermore, the 2,2-diphenyl-2,3-dihydro-imidazol1,2-a] benzimidazol-3-one can be prepared by thermolysis of 1-aryl-2-cyano-3,3-diphenyl-diazetidin-4-one (CW.BIRD, MWKACZMAR, CKWONG: Tetrahedron 30, 2549 (19741).) The 2,2-disubstituted 2,3-dihydroimidazo [1,2-a] benzimidazol-3-ones required as starting materials were obtained from 2 -Amino-benzimidazole, chloroform and acetone or cyclohexanone and subsequent cyclization with thionyl chloride (H.GRAUBAUM, R.OZEGOWSKI: J.prakt. Chem: in preparation) prepared by known methods.

Ziel der ErfindungObject of the invention

Es ist das Ziel der Erfindung, ein selektives Verfahren zur Herstellung von neuen 2,2-disubsituierten 1 -Acyl- und/oder 9-Acyl-2,3-dihydro-imidazo(1,2-a]benzimidazol-3-onen zu entwickeln, das keine komplizierten Verfahrens- oder Trennschritte erfordert und durch das eine Vielzahl von Verbindungen mit unterschiedlichen Substituentenmustern zugänglich wird.It is the object of the invention to provide a selective process for the preparation of novel 2,2-disubstituted 1-acyl and / or 9-acyl-2,3-dihydroimidazo (1,2-a) benzimidazol-3-ones which does not require complicated process or separation steps and which makes a variety of compounds having different substituent patterns available.

Darlegung des Wesens der ErfindungExplanation of the essence of the invention

Aufgabe der Erfindung ist es, durch Acylierung von 2,2-disubstituierten 1 (9)-H-2,3-Dihydro-imidazol1,2-a]benzimidazol-3-onen das Ziel der Erfindung erreichen.The object of the invention is to achieve the object of the invention by acylation of 2,2-disubstituted 1 (9) -H-2,3-dihydro-imidazol1,2-a] benzimidazol-3-ones.

Diese Aufgabe wird gelöst durch ein Verfahren zur Herstellung neuer 2,2-disubstituierter 1-Acyl- oder 9-Acyl-2,3-dihydroimidazo(1,2-a]benzimidazol-3-one der allgemeinen Formel 3 bzw. 2,This object is achieved by a process for the preparation of novel 2,2-disubstituted 1-acyl or 9-acyl-2,3-dihydroimidazo (1,2-a) benzimidazol-3-ones of the general formula 3 or 2,

7 »

in der bedeuten: —in which mean: -

R, R': jeweils Methyl oder gemeinsam Pentamethylen,R, R ': in each case methyl or together pentamethylene,

Acyl: COR', COOR2, C(=NH)OR2, CONHR2 oder CI=S)OR2, wobei R2 Alkyl oder gegebenenfallsAcyl: COR ', COOR 2 , C (= NH) OR 2 , CONHR 2 or CI = S) OR 2 , where R 2 is alkyl or optionally

substituiertes Aryl sein kann,may be substituted aryl,

indem man erfindungsgemäß ein Säurechlorid der allgemeinen Formel R2COCI, ein Kohlensäure-ester-chlorid der allgemeinen Formel R2COOCI, ein Cyansäureester der allgemeinen Formel R2OCN, ein Isocyansäureester R2NCO oder ein Thiokohlensäureester-Ö-ester-chlorid der allgemeinen Formel R2OCSCI mit einem 2,2-disubstituierten 2,3-Dihydro-imidazo[1,2-a]benzimidazol 1, bei der R und R1 die oben genannten Bedeutungen haben, bei Temperaturen von -10O0C bis +2000C umsetzt.by according to the invention an acid chloride of the general formula R 2 COCI, a carbonic acid ester chloride of the general formula R 2 COOCI, a cyanic acid ester of the general formula R 2 OCN, an isocyanic ester R 2 NCO or a Thiokohlensäureester-Ö-ester chloride of the general Formula R 2 OCSCI with a 2,2-disubstituted 2,3-dihydro-imidazo [1,2-a] benzimidazole 1 in which R and R 1 have the abovementioned meanings, at temperatures from -10O 0 C to +200 0 C converts.

In Abhängigkeit vom Aryl rest und von der Reaktionstemperatur entstehen dabei selektiv die 1-Acy !derivate 3 oder die isomeren 9-Acylderivate 2. Die bei Temperaturen von -1000C bis 50°C entstehenden Verbindungen 2 lassen sich thermisch bei Temperaturen von 1O0C bis 2000C mit und ohne Lösungsmittel zu 3 isomerisieren, wobei als Lösungsmittel zum Beispiel Acetonitril, Dioxan, DMF, DMSO oder Pyridin verwendet werden kann.Depending on the aryl radical and originate from the reaction temperature, thereby selectively 1-acylphenylalanine derivatives 3 or the isomeric 9-acyl derivatives 2. The compounds 2 formed at temperatures from -100 0 C to 50 ° C can be thermally at temperatures of from 1O 0 C to 200 0 C with and without solvent isomerize to 3, wherein as a solvent, for example, acetonitrile, dioxane, DMF, DMSO or pyridine can be used.

Es lassen sich auch die Verbindungen 3 direkt aus 1 und dem entsprechenden Acylierungsmittel darstellen, ohne Isolierung der isomeren Verbindungen 2 (siehe Beispiel 4). Bei der Reaktion von 1 mit Cyansäureestern und Isocyansäureestern (Methode A) wird erfindungsgemäß in einem aprotischen Lösungsmittel gearbeitet, bei der Umsetzung mit Säurechloriden, Kohlensäureester-chloriden oder Thiokohlensäure-O-ester-chloriden ist ein säurebindendes Mittel, z. B. Triethylamin, Na2CO3 oder Pyridin, vorteilhaft (Methode B).It can also be the compounds 3 directly from 1 and the corresponding acylating agent, without isolation of the isomeric compounds 2 (see Example 4). In the reaction of 1 with cyanic acid esters and isocyanic acid esters (Method A) is carried out according to the invention in an aprotic solvent, in the reaction with acid chlorides, carbonic acid ester chlorides or thiocarbonic O-ester chlorides is an acid-binding agent, eg. As triethylamine, Na 2 CO 3 or pyridine, advantageous (method B).

Die Verfahrensprodukte fallen, gegebenenfalls nach Einengen des Lösungsmittels oder Ausfällen mit Wasser, in guten Ausbeuten an und werden nach bekannten Methoden isoliert (siehe Tabelle 1 und 2). Die Strukturen der erhaltenen Umsetzungsprodukte ergeben sich aus den Elementaranalysen, Massen-, 1H- und 13C-NMR-Spektren.The process products are obtained, if appropriate after concentration of the solvent or precipitation with water, in good yields and are isolated by known methods (see Table 1 and 2). The structures of the resulting reaction products are derived from elemental analyzes, mass, 1 H and 13 C NMR spectra.

Ausführungsbeispieleembodiments

Methode AMethod A

lOmmol 2,2-Dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on werden in 10ml Aceton gelöst. Dazu werden bei -7O0C lOmmol Phenylisocyanat getropft. Nach wenigen Minuten schneiden sich weiße Kristalle ab, das Produkt wird abgesaugt und getrocknet. Es werden 80% des S-Phenyl-carbamoyl^-dimethyl^S-dihydro-imidazololi^-albenzimidazol-S-on (2f) (Fp. 178 bis 1800C) isoliert (siehe Tabelle 1).10 mmol of 2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one are dissolved in 10 ml of acetone. These are added dropwise at -7O 0 C lOmmol phenyl isocyanate. After a few minutes, white crystals cut off, the product is filtered off with suction and dried. There are 80% of the S-phenyl-carbamoyl ^ dimethyl ^ S-dihydro-imidazololi ^ -albenzimidazol-S-one (2f) (mp. 178-180 0 C) was isolated (see Table 1).

Methode BMethod B

lOmmol 2,2-Dimethyl-2,3-dihydro-imidazo[1,2-albenzimidazol-3-on werden in 15ml THF bei 10 bis 150C vorgelegt. Dazu werden lOmmol Kohlensäure-ethylester-chlorid und anschließend lOmmol Triethylamin getropft. Nach einstündigem Rühren bei Raumtemperatur werden 30 ml Wasser addiert, der ausfallende Niederschlag abgesaugt und getrocknet. Es werden 70% 9-Ethoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (21) (Fp. 144-1450C) isoliert (siehe Tabelle 1). 6somerisierungen 2 —*> 3lOmmol of 2,2-dimethyl-2,3-dihydro-imidazo [1,2-albenzimidazol be on-3-introduced into 15 ml of THF at 10 to 15 0 C. For this purpose, 10 mmol of carbonic acid ethyl ester chloride and then 10 mmol of triethylamine are added dropwise. After one hour of stirring at room temperature, 30 ml of water are added, the precipitate sucked off and dried. There are 70% 9-ethoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazole-3-one (21) (mp. 144-145 0 C) was isolated (see Table 1 ). 6somerizations 2 - *> 3

Beispiel 1example 1

lOmmol 9-Phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (2m) werden 24 Stunden in 20ml Aceton bei Raumtemperatur gerührt, das Produkt wird abgesaugt und getrocknet. Es können 84% i-Phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (3m) erhalten werden (siehe Tabelle 2).10 mmol of 9-phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (2 ml) are stirred for 24 hours in 20 ml of acetone at room temperature, the product is filtered off with suction and dried. There can be obtained 84% i-phenoxycarbonyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (3m) (see Table 2).

Beispiel 2Example 2

1 g 9-Methylcarbomoyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (2β) wird in 5 ml DMSO kurz zum Sieden erhitzt. Beim Abkühlen fallen 89% 1-Methylcarbamoyl-2,2-dimethyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-on (3e) aus (siehe Tabelle 2).1 g of 9-methylcarbamoyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (2β) is briefly boiled in 5 ml of DMSO. Upon cooling, 89% of 1-methylcarbamoyl-2,2-dimethyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-one (3e) precipitate (see Table 2).

Beispiel 3Example 3

1 g O-Acotyl^^-dlmothyl^.a-dlhydro-lmldazoII^-nlbonzlmldoiol-a-on (2 b) wird 1 Stundo bei 200°C ohno Lösungsmittel erwärmt. Nach dom Abkühlon wordon 92% i-Acetyl^-dlmothyl^-dihydro-lmldazoli^-albonzlmldazol-S-on (3b) Isollorl {siehe Tabelle 2).1 g O-Acotyl ^^ - dlmothyl ^ .a-dlhydro-lmldazoII ^ -nlbonzlmldoiol-a-on (2 b) is heated for 1 hour at 200 ° C without solvent. After cooling, the product was 92% i-acetyl -dlmothyl-dihydro-imidazolium-alzolmidazol-S-one (3b) iso-norol (see Table 2).

Beispiel 4Example 4

Zu lOmmol 2,2·Dimethyl 2,3·dihγdro·imldazo(1,2·a]benzlmldazol·3-on In 20ml Acetonitril worden bei Raumtemperatur 10mmol 4-Chlorphenyllsocyanat gotropft. Anschließend wird dlo Lösung 10 Minuten zum Sieden orhitzt. Boim Abkühlon fallen 71%1-(4-Chlorphonylcarbomoyl)-2,2-dlmothyl-2,3-dihydro-lmldnzo[1,2-a]bonzlmklQzol-3-on(3l)nus(plohoTabollo2).10 mmol of 4-chlorophenyl phthalocyanate was added dropwise to 20 ml of acetonitrile in 20 ml of acetonitrile at room temperature, then the solution was refluxed for 10 minutes 71% of 1- (4-chloroporonylcarbamoyl) -2,2-dlmothyl-2,3-dihydro-imidnzo [1,2-a] -benzylmkt-3-one (3l) nus (plohoTabollo2).

2l2-Disubstituierte9-Acyl-2,3-dihydro-imidazo[1,2-a]bonzimidazol-3-ono(2a-p) R1 2 l of 2-disubstituted 9-acyl-2,3-dihydro-imidazo [1,2-a] -bonzimidazol-3-oneo (2a-p) R 1

Acylacyl

Ausb. MethodeY. method

Fpfp

(0C)( 0 C)

Summenformol (Molmasse)Total formula (molecular weight)

2a2a CH3 CH 3 CH3 CH 3 Ci=NH)OCH2CCI3 Ci = NH) OCH 2 CCI 3 4040 AA 2b2 B CH3 CH 3 CH3 CH 3 COCHjCOCHj 8585 BB 2c2c CH3 CH 3 CH3 CH 3 COCjH6 COCjH 6 8484 BB 2d2d CH3 CH 3 CH3 CH 3 COC6H6 COC 6 H 6 9292 BB 2o2o CH3 CH 3 CH3 CH 3 CONHCH3 CONHCH 3 9393 AA 2f2f CH3 CH 3 CH3 CH 3 CONHC6H6 CONHC 6 H 6 8080 AA 2a2a CH3 CH 3 CH3 CH 3 CONHCeH4-CH(CH3)2-4CONHC e H4-CH (CH 3 ) 2-4 7070 AA 2121 CH3 CH 3 CH3 CH 3 CONHC6H4-CMCONHC 6 H 4 -CM 7171 AA 2k2k CH3 CH 3 CH3 CH 3 COOCH3 COOCH 3 6666 BB 2121 CH3 CH 3 CH3 CH 3 COOC2H6 COOC 2 H 6 7070 BB 2m2m CH3 CH 3 CH3 CH 3 COOC6H6 COOC 6 H 6 4949 BB 2n2n CH3 CH 3 CH3 CH 3 CI=S)OC8H4-OCHr^CI = S) OC 8 H 4 -OCHR ^ 8282 BB 2o2o -CH2 -CH 2 (CH2I3CH2-(CH 2 I 3 CH 2 - CONHCH3 CONHCH 3 8080 BB 2p2p -CH2 -CH 2 (CHj)3CHr-(CHj) 3 CHr- CONHC6H6 CONHC 6 H 6 8989 BB

176-178b) 176-178 b) C14H13CI3N4OjC 14 H 13 CI 3 N 4 Oj (375,7/375)(375.7 / 375) 188-190bl 188-190 bl C13H13N3O2 C 13 H 13 N 3 O 2 (243,3/243)(243.3 / 243) 166-167b) 166-167 b) C16H16N3O2 C 16 H 16 N 3 O 2 (257,3)(257.3) 147-148°'147-148 ° ' C18H16N3O,C 18 H 16 N 3 O, (305,3)(305.3) 165-166b) 165-166 b) C13H14N4O2 C 13 H 14 N 4 O 2 (258,3/258)(258.3 / 258) 178-180bli) 178-180 bli) C18H16N4O2 C 18 H 16 N 4 O 2 (320,4/320)(320.4 / 320) 143-144blel 143-144 blel C21Hj2N4O2 C 21 Hj 2 N 4 O 2 (362,4)(362.4) 235-236"""235-236 "" " C18H16CIN4O2 C 18 H 16 CIN 4 O 2 (354,8)(354.8) 178-180b) 178-180 b) C13H13N3O3 C 13 H 13 N 3 O 3 (259,3/259)(259.3 / 259) 144-145«"144-145 ' " C14H16N3O3 C 14 H 16 N 3 O 3 (273,3)(273.3) 178-179bW 178-179 bw C18H16N3O3 C 18 H 16 N 3 O 3 (321,3)(321.3) 127-128b) 127-128 b) C19H17N3O3SC 19 H 17 N 3 O 3 S (367,4)(367.4) 295-297"""295-297 "" " C16H18N4O2 C 16 H 18 N 4 O 2 (298,4)(298.4) 185-186bl"185-186 bl " C21H20N4O2 C 21 H 20 N 4 O 2 (360,4/360)(360.4 / 360)

11 MS-Mol-Peak, bl aus CH3CN, "aus EtOH, "'ausBenzen/Petrolether *' Beim Umkristallisieren findet bereits eine teilweise Isomerisierung zu 3 statt. 11 MS-mole peak, bl out of CH 3 CN, "from EtOH,"'from benzene / petroleum ether *' Recrystallization already leads to a partial isomerization to 3.

Tab. 2 2,2-Disubstituierte1-Acyl-2,3-dihydro-imidazo[1,2-a]benzimidazol-3-one(3a-q)Tab. 2 2,2-Disubstituted 1-acyl-2,3-dihydro-imidazo [1,2-a] benzimidazol-3-ones (3a-q)

R1 R 1

R2 R 2

Acylacyl

Ausb. FpY. fp

(0O( 0 o

SummenformelMolecular formula

(Molmasse"1 (Molecular weight " 1

ber.[gef.])calc. [gef.])

3a3a CH3 CH 3 CH3 CH 3 CI=NH)OCHjCCI3 CI = NH) OCHjCCI 3 3b3b CH3 CH 3 CH3 CH 3 COCH3 COCH 3 3e3e CH3 CH 3 CH3 CH 3 CONHCH3 CONHCH 3 3f3f CH3 CH 3 CH3 CH 3 CONHC6H6 CONHC 6 H 6 3g3g CH3 CH 3 CH3 CH 3 CONHC6H4-CH(CH3)J-^CONHC 6 H 4 -CH (CH 3 ) J- ^ 3h3h CH3 CH 3 CH3 CH 3 CONHNapth-1-ylCONHNapth-1-yl 3!3! CH3 CH 3 CH3 CH 3 CONHC6H4-CMCONHC 6 H 4 -CM

9191 176-178bl 176-178 bl 9292 188-190bl 188-190 bl 8989 165-166"1 165-166 " 1 7575 178-180bl 178-180 bl 8989 143-144«»143-144 '' 8282 188-189bl 188-189 bl 7171 235-236*'235-236 * '

C14H13CI3N4O2 C 14 H 13 Cl 3 N 4 O 2

(375,7)(375.7)

C13H13N3O2 C 13 H 13 N 3 O 2

(243,3/243)(243.3 / 243)

C13H14N4O2 C 13 H 14 N 4 O 2

(258,3/258)(258.3 / 258)

C18H10N4O2 C 18 H 10 N 4 O 2

(320,4)(320.4)

C21H22N4O2 C 21 H 22 N 4 O 2

(362,4)(362.4)

C22H18N4O2 C 22 H 18 N 4 O 2

(370,4)(370.4)

C18H16CIN4O2 C 18 H 16 CIN 4 O 2

(354,8)(354.8)

Fortsetzung Tob.2Continued Tob.2

R1 R 1

R2 R 2

Acyl Ausb.Acyl Ausb.

Fpfp

(1C) (1 C)

SurnmonformolSurnmonformol

(Molmasso"'(Molmasso ''

bor.|gof.|)) |. Bor |. Gof

3| CH3 3 k CH3 2 m CHj3 | CH 3 3k CH 3 2 m CHj

CH3 CH3 CH3 CH 3 CH 3 CH 3

COOCH3 COOC4H6 COOCH 3 COOC 4 H 6

2 ρ -CH2(CHj)3CH2- CONHC6H6 3q -CH2(CHj)3CH2- CONHC6H4-CH(CH3)j-42 ρ -CH 2 (CHj) 3 CH 2 -CONHC 6 H 6 3q -CH 2 (CHj) 3 CH 2 -CONHC 6 H 4 -CH (CH 3 ) j-4

6868 216-216"'216-216 " ' CeH14CI2N4O2 CeH 14 Cl 2 N 4 O 2 (389,3)(389.3) 9090 188-189"'188-189 " ' CuHuNjO3 CuHuNjO 3 (259,3)(259.3) 8484 199-200bl 199-200 bl C16H16N3O3 C 16 H 16 N 3 O 3 (321,3)(321.3) 8080 295-297cl 295-297 cl C21H20N4O2 C 21 H 20 N 4 O 2 (360,4/360)(360.4 / 360) 8282 295-297°'295-297 ° ' C24H26N4O2 C 24 H 26 N 4 O 2 (402,6/402)(402.6 / 402)

11 MS-Mol-Peak "' aus CH1CN, cl ausDioxan 11 MS mol peak '' from CH 1 CN, cl from dioxane

Formel blattFormula sheet

O R"O R "

Claims (3)

1. Verfahren zur Herstellung von 2,2-diaubslltulerton 1-Acyl· und/oder 9-Acyl-2,3-dlhydrolmldazo|1,2-a]bonzimldazol-3-onen der allgemeinen Formel 3 oder 2, in der bedeuten: R, R1: jeweils Methyl oder gemeinsam Pentamothylen,1. A process for the preparation of 2,2-diazobenzlertone 1-acyl and / or 9-acyl-2,3-dlhydrolmldazo-1,2-a] -benzimidazol-3-one of general formula 3 or 2, in which: R, R 1 : in each case methyl or together pentamothylene, Acyl: COR2, C(=NH)OR2, COOR2, CONHR2, C(=S)OR2, wobei R2 Alkyl oder gegebenenfalls substituiertes Aryl sein kann,Acyl: COR 2 , C (= NH) OR 2 , COOR 2 , CONHR 2 , C (= S) OR 2 , where R 2 may be alkyl or optionally substituted aryl, dadurch gekennzeichnet, daß 2,2-disubstitulerte 2,3-DlhydiO-imidazo[1,2-a]benzimidazol-3-one der allgemeinen Formel 1 mit einem Änderungsmittel wie Säurechlorid, Kohlensäureester-chlorid oder Thiokohlensäure-O-ester-chlorid in Gegenwart eines säurebindenden Mittels oder mit einem Acylierungsmittol wie Cyansäureester oder Isocyansäureester in Gegenwart eines aprotischen Lösungsmittels bei Temperaturen von -10O0C bis +2000C umgesetzt werden.characterized in that 2,2-disubstituted 2,3-DlhydiO-imidazo [1,2-a] benzimidazol-3-one of the general formula 1 with a changing agent such as acid chloride, carbonic acid chloride or thiocarbonic O-ester chloride in In the presence of an acid-binding agent or with an acylating agent such as cyanic acid ester or isocyanic acid ester in the presence of an aprotic solvent at temperatures of -10O 0 C to +200 0 C are reacted. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß als säurebindendes Mittel Triethylamin, Natriumkarbonat oder Pyridin verwendet wird.2. The method according to claim 1, characterized in that triethylamine, sodium carbonate or pyridine is used as the acid-binding agent. 3. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß die 2,2-disubstituierten 9-Acyl-2,3-dihydro-imidazo[1,2-albenzimidazol-3-one 2 thermisch bei Temperaturen von 10 bis 2000C zu den 2,2-disubstituierten 1-Acyl-2,3-dihydro-imidazo(1,2-albenzimidazol-3-onen isomerisiert werden.3. The method according to claim 1, characterized in that the 2,2-disubstituted 9-acyl-2,3-dihydro-imidazo [1,2-albenzimidazol-3-one 2 thermally at temperatures of 10 to 200 0 C to the 2,2-disubstituted 1-acyl-2,3-dihydro-imidazo (1,2-albenzimidazol-3-ones are isomerized.
DD33950390A 1990-04-06 1990-04-06 PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN DD293352A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD33950390A DD293352A5 (en) 1990-04-06 1990-04-06 PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD33950390A DD293352A5 (en) 1990-04-06 1990-04-06 PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN

Publications (1)

Publication Number Publication Date
DD293352A5 true DD293352A5 (en) 1991-08-29

Family

ID=5617644

Family Applications (1)

Application Number Title Priority Date Filing Date
DD33950390A DD293352A5 (en) 1990-04-06 1990-04-06 PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN

Country Status (1)

Country Link
DD (1) DD293352A5 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050425A1 (en) * 1999-02-22 2000-08-31 Boehringer Ingelheim Pharmaceuticals, Inc. Polycyclo heterocyclic derivatives as antiinflammatory agents
US6333325B1 (en) 1999-01-19 2001-12-25 Boehringer Ingelheim Pharmaceuticals, Inc. Method of treating cytokine mediated diseases or conditions
US6358945B1 (en) 1999-03-12 2002-03-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US6753426B2 (en) 1999-07-09 2004-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Polymorph and process for preparing same

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333325B1 (en) 1999-01-19 2001-12-25 Boehringer Ingelheim Pharmaceuticals, Inc. Method of treating cytokine mediated diseases or conditions
US6506748B2 (en) 1999-01-19 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as antiinflammatory agents
WO2000050425A1 (en) * 1999-02-22 2000-08-31 Boehringer Ingelheim Pharmaceuticals, Inc. Polycyclo heterocyclic derivatives as antiinflammatory agents
US6242453B1 (en) 1999-02-22 2001-06-05 Boehringer Ingelheim Pharmaceuticals, Inc Polycyclo heterocyclic derivatives as antiinflammatory agents
US6358945B1 (en) 1999-03-12 2002-03-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US6660732B2 (en) 1999-03-12 2003-12-09 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US7019006B2 (en) 1999-03-12 2006-03-28 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US6753426B2 (en) 1999-07-09 2004-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. Polymorph and process for preparing same
US6774233B2 (en) 1999-07-09 2004-08-10 Boehringer Ingelheim Pharmaceuticals, Inc. Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
US6835832B2 (en) 1999-07-09 2004-12-28 Boehringer Ingelheim Pharmaceuticals, Inc. Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
US6894173B2 (en) 1999-07-09 2005-05-17 Boehringer Ingelheim Pharmaceuticals, Inc. Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same

Similar Documents

Publication Publication Date Title
DE2162096C2 (en)
CH634306A5 (en) BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTHELMINTIC AGENTS CONTAINING THESE COMPOUNDS AS ACTIVE INGREDIENTS.
EP0413226B1 (en) [1,2,4]Triazo [1,5-a]pyridine
DE2259220A1 (en) CONDENSATION PRODUCTS AND THEIR APPLICATION
DE2858737C2 (en)
US4665097A (en) Novel bicyclooxyaryl thioureas and process for preparation
DE2003841B2 (en) VIRUCIDE AND IMMUNSUPPRESSIVE AGENTS
DE2413966A1 (en) OXAMIC ACID DERIVATIVES
DD293352A5 (en) PROCESS FOR PREPARING 2,2-DISUBSTITUTED 1-ACYL AND / OR 9-ACYL-2,3-DIHYDRO-IMIDAZO / 1,2-A / BENZIMIDAZOLE-3-ONEN
DE2845435A1 (en) METHOD FOR PRODUCING 2,6-DIAMINONEBULARINES
CH634307A5 (en) ANTHELMINTICALLY ACTIVE BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDIUM CONTAINING THESE ACTIVE SUBSTANCES.
DE2229248B2 (en) 5-Iminomethyl-2-nitroimidazole derivatives and process for their preparation
DE3151450A1 (en) N-Phenoxysulphonylureas, their preparation and their use
DE2512171A1 (en) 2,3-DIHALOGEN-ALKANOYL-UREA, METHOD FOR THEIR MANUFACTURE AND THEIR USE AS FUNGICIDES
DE1470361C3 (en) 5,6-Dihydro-6-oxo-pyrido square bracket to 2,3-square bracket to square bracket to 1,4 square bracket to -benzoxazepine and process for its preparation
EP0417875B1 (en) 1-methoxypyrimidinyl-1h-1,2,4-triazole-3-sulfonic acid nitroanilides, process for their preparation and their use as agents with herbicidal activity
EP0097614B1 (en) Pesticides
EP0091593A1 (en) N-pteridinyl ureas, process for their preparation and their use
DE1568021C3 (en) New Isothiocyano diphenylather and diphenylthioather, their produc- tion and means for combating parsi tarer helminths and for preventing helminthiases in humans and animals
DE2254474A1 (en) HYDROXYIMIDAZOLE, THE PROCESS FOR THEIR MANUFACTURING AND PESTICIDES CONTAINING THESE COMPOUNDS
DE2624856A1 (en) Anthelmintic thio-barbituric acid derivs. - have (5)-benzyl-thiocarbamoyl substit. and are esp. useful for control of liver flukes
AT312988B (en) Fungicides
DE2428640A1 (en) ANTHELMINTIC COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION
DE2236339A1 (en) Alpha-cyano-hydrazones preparation - with pre and post-emergence herbici-dal activity
AT358594B (en) METHOD FOR PRODUCING NEW 2-CYCLO-PROPYLAMINO-4,6-DIAMINO-S-TRIAZINES OR THEIR ACID ADDITION SALTS

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee